2016
DOI: 10.1016/j.jinorgbio.2016.06.009
|View full text |Cite
|
Sign up to set email alerts
|

Labile Pd-sulphur and Pt-sulphur bonds in organometallic palladium and platinum complexes [(COD)M(alkyl)(S-ligand)]n+—A speciation study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 14 publications
(4 citation statements)
references
References 123 publications
(160 reference statements)
0
4
0
Order By: Relevance
“…In particular, a considerable effort is being devoted toward the development of organometallic compounds with antitumor activity. , The library of organometallic species with antiproliferative activities has seen marked growth in recent years with reports on organometallic compounds. Among the transition metals, organometallic compounds of ruthenium , and gold , have been studied most extensively as antitumor agents. On the other hand, reports on Pt­(II)-based organometallics in the same context are relatively less in number. Most of the reported organoplatinum­(II) compounds have an exchangeable and labile alkene ligand (1,5-cyclooctadiene) bound to the Pt­(II) center. Additionally, there are some examples of cyclometalated organometallic complexes of Pt­(II) that are reportedly biologically active and are potential anticancer agents …”
Section: Introductionmentioning
confidence: 99%
“…In particular, a considerable effort is being devoted toward the development of organometallic compounds with antitumor activity. , The library of organometallic species with antiproliferative activities has seen marked growth in recent years with reports on organometallic compounds. Among the transition metals, organometallic compounds of ruthenium , and gold , have been studied most extensively as antitumor agents. On the other hand, reports on Pt­(II)-based organometallics in the same context are relatively less in number. Most of the reported organoplatinum­(II) compounds have an exchangeable and labile alkene ligand (1,5-cyclooctadiene) bound to the Pt­(II) center. Additionally, there are some examples of cyclometalated organometallic complexes of Pt­(II) that are reportedly biologically active and are potential anticancer agents …”
Section: Introductionmentioning
confidence: 99%
“…(2) has approximate C 2 symmetry, which results in a signal for the olefinic proton and carbon atoms in 1 H and 13 C spectra, whereas [PtCl(sac)(COD)] (1) gives 2 signals in the NMR spectra for the corresponding groups due to the difference in the trans effects of the chlorido and sac ligands. The complexes exhibit high thermal stability in air.…”
Section: Discussionmentioning
confidence: 99%
“…Organoplatinum(II) complexes [Pt(R)(L)(COD)] (R = organic groups such as alkyl, aryl or alkynyl; L = other ligands) received great interest and were widely used in catalysis [6][7][8][9][10], material science [11,12] and medicinal research as anticancer agents [13][14][15][16][17][18][19].…”
Section: Introductionmentioning
confidence: 99%
“…It should be also underlined that there is a limited number of studies on platinum organometallic compounds tested as antitumor drugs [ 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 ]. In this regard, the Zeise’s anion, [PtCl 3 (η 2 -C 2 H 4 )] − , showing an extreme lability of the trans to olefin chlorido ligand and a peculiar reactivity of the coordinated ethene, resulted to be a suitable precursor for the synthesis of new antitumor organometallic complexes [ 19 ].…”
Section: Introductionmentioning
confidence: 99%